Cymabay Therapeutics Inc sell Midas
Start price
12.02.21
/
50%
€4.80
Target price
12.02.22
-
Performance (%)
-36.21%
End price
25.08.21
€3.06
Summary
This prediction ended on 25.08.21 with a price of €3.06. Midas correctly predicted massive losses of -36.21% for Cymabay Therapeutics Inc. Midas has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cymabay Therapeutics Inc | - | - | - | - |
| iShares Core DAX® | 0.191% | 4.892% | 22.046% | 64.626% |
| iShares Nasdaq 100 | -0.614% | 2.901% | 7.804% | 109.421% |
| iShares Nikkei 225® | 0.599% | 7.404% | 22.218% | 57.591% |
| iShares S&P 500 | -0.036% | 3.489% | 4.833% | 68.003% |
Comments by Midas for this prediction
In the thread Cymabay Therapeutics Inc diskutieren
Sell Cymabay Therapeutics Inc